ATAI Life Sciences BV (ATAI) — Financial Flexibility Index
ATAI Life Sciences BV (ATAI) has a Financial Flexibility Index of -0.32x as of March 2026. Free cash flow of $-21.09 Million (operating CF $-21.09 Million minus capex $0.00) represents 0% of total liabilities ($66.10 Million). Check ATAI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ATAI Life Sciences BV Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for ATAI Life Sciences BV across 7 annual periods. See ATAI working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ATAI Life Sciences BV (2019–2025)
Year-by-year free cash flow to debt coverage for ATAI Life Sciences BV. For the full company profile including market capitalisation, see ATAI stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.15x | $-101.77 Million | $-102.67 Million | $88.54 Million | ▲ +40.2% |
| 2024 | -1.92x | $-82.34 Million | $-82.44 Million | $42.83 Million | ▼ -13.1% |
| 2023 | -1.70x | $-83.53 Million | $-84.12 Million | $49.16 Million | ▲ +34.8% |
| 2022 | -2.61x | $-103.44 Million | $-104.47 Million | $39.67 Million | ▼ -18.4% |
| 2021 | -2.20x | $-62.12 Million | $-63.25 Million | $28.21 Million | ▼ -72.1% |
| 2020 | -1.28x | $-20.71 Million | $-20.77 Million | $16.18 Million | ▲ +61.8% |
| 2019 | -3.35x | $-7.83 Million | $-7.85 Million | $2.34 Million | — |